- Maintenance of CD8+T-cell anergy by CD4+CD25+ regulatory T cells in chronic graft-versus-host disease
-
Kim J, Kim HJ, Choi WS, Nam SH, Cho HR, Kwon B
- KMID: 1098083
- Exp Mol Med.
- 2006 Oct;38(5):494-501.
In a murine model of systemic lupus erythematosus (SLE)-like chronic graft-versus-host disease (cGVHD), donor CD8+T cells rapidly fall into anergy to host cells, while donor CD4+T cells hyperactivate B cells... -
- CITED
-
- Close
- SHARE
-
- Close
- The presence of CD8+ invariant NKT cells in mice
-
Lee H, Hong C, Shin J, Oh S, Jung S, Park YK, Hong S, Lee GR, Park SH
- KMID: 1099863
- Exp Mol Med.
- 2009 Dec;41(12):866-872.
- doi: 10.3858/emm.2009.41.12.092
Invariant natural killer T (iNKT) cells develop in the thymus upon recognition of CD1d expressed on developing thymocytes. Although CD4 and CD8 coreceptors are not directly involved in the interaction... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Hepatitis C Virus Core Protein in Hepatocytes Does Not Modulate Proliferation or Apoptosis of CD8+ T Cells
-
Jin YH, Crispe IN, Park S
- KMID: 2428300
- Yonsei Med J.
- 2005 Dec;46(6):827-834.
Hepatocytes are the primary targets of the hepatitis C virus (HCV). While immunosuppressive roles of HCV core protein have been found in several studies, it remains uncertain whether core protein... -
- CITED
-
- Close
- SHARE
-
- Close
- Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection
-
Yoo KI, Jeon JY, Ryu SJ, Nam G, Youn H, Choi EY
- KMID: 2155405
- Exp Mol Med.
- 2015 Feb;47(2):e140.
- doi: 10.1038/emm.2014.107
In allogeneic transplantation, including the B6 anti-BALB.B settings, H60 and H4 are two representative dominant minor histocompatibility antigens that induce strong CD8 T-cell responses. With different distribution patterns, H60 expression... -
- CITED
-
- Close
- SHARE
-
- Close
- HBV-specific CD8+ T cells for Sustained HBeAg Seroconversion after Lamivudine Therapy
-
Lee CK, Han KH, Suh JH, Cho YS, Won SY, Chon CY, Moon YM, Park IS
- KMID: 760578
- Korean J Hepatol.
- 2005 Mar;11(1):34-42.
BACKGROUND/AIMS: Viral suppression of the hepatitis B virus (HBV) can be induced by lamivudine, but the relapse seen in many patients after cessation of lamivudine therapy is troublesome. We... -
- CITED
-
- Close
- SHARE
-
- Close
- CD8+ T-cell Activation in Mice Injected with a Plasmid DNA Vaccine Encoding AMA-1 of the Reemerging Korean Plasmodium vivax
-
Kim HJ, Jung BK, Lee JJ, Pyo KH, Kim TY, Choi BI, Kim TW, Hisaeda H, Himeno K, Shin EH, Chai JY
- KMID: 1715639
- Korean J Parasitol.
- 2011 Mar;49(1):85-90.
- doi: 10.3347/kjp.2011.49.1.85
Relatively little has been studied on the AMA-1 vaccine against Plasmodium vivax and on the plasmid DNA vaccine encoding P. vivax AMA-1 (PvAMA-1). In the present study, a plasmid DNA... -
- CITED
-
- Close
- SHARE
-
- Close
- Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells
-
Park SN, Noh KT, Jeong YI, Jung ID, Kang HK, Cha GS, Lee SJ, Seo JK, Kang DH, Hwang TH, Lee EK, Kwon B, Park YM
- KMID: 2154227
- Exp Mol Med.
- 2013 Feb;45(2):e8.
We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin... -
- CITED
-
- Close
- SHARE
-
- Close
